Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acromegaly | D000172 | — | — | 1 | — | 2 | 4 | — | 7 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | 1 | — | 2 |
Meningioma | D008579 | EFO_0003098 | D32.9 | — | 1 | — | 1 | — | 2 |
Medulloblastoma | D008527 | — | — | — | — | — | 1 | — | 1 |
Paraganglioma | D010235 | — | — | — | — | — | 1 | — | 1 |
Pituitary neoplasms | D010911 | — | — | — | — | — | 1 | — | 1 |
Hemangioblastoma | D018325 | — | — | — | — | — | 1 | — | 1 |
Olfactory esthesioneuroblastoma | D018304 | EFO_1000407 | — | — | — | — | 1 | — | 1 |
Hyperglycemia | D006943 | — | R73.9 | — | — | — | 1 | — | 1 |
Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 1 | 2 | 1 | — | — | 4 |
Carcinoid tumor | D002276 | — | D3A.00 | 2 | — | 1 | — | — | 3 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | 1 | — | — | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | — | C34.90 | 1 | 3 | — | — | — | 4 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 1 | 1 | — | — | 2 | 4 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 2 |
Neuroendocrine carcinoma | D018278 | — | — | — | 1 | — | — | — | 1 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | — | — | — | 1 |
Thyroid diseases | D013959 | — | E00-E07 | — | 1 | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Paraneoplastic syndromes | D010257 | — | — | 1 | — | — | — | — | 1 |
Nervous system neoplasms | D009423 | — | — | 1 | — | — | — | — | 1 |
Islet cell adenoma | D007516 | EFO_0007331 | D13.7 | 1 | — | — | — | — | 1 |
Malignant carcinoid syndrome | D008303 | — | E34.0 | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | — | — | — | — | 1 |
Intestinal neoplasms | D007414 | — | C26.0 | 1 | — | — | — | — | 1 |
Drug common name | Somatostatin |
INN | somatostatin |
Description | SOMATOSTATIN |
Classification | Protein |
Drug class | growth hormone derivatives; enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O |
PDB | — |
CAS-ID | 38916-34-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1823872 |
ChEBI ID | 64628 |
PubChem CID | — |
DrugBank | — |
UNII ID | 6E20216Q0L (ChemIDplus, GSRS) |